Roche meanwhile already has the comfort of one positive result for giredestrant from the coopERA study in post ... which was reported at last year's ESMO meeting. In that trial, the SERD performed ...
The results of the GALAXIES Lung-02 study reported at the ESMO congress in Barcelona showed that the drug – added to GSK's PD-1 inhibitor Jemperli (dostarlimab) – achieved a higher objective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback